3rd ESTRO Forum 2015 the only OARs to be significantly affected by applying these moves and in these cases no clinically significant deviations were observed. Conclusions: Variations in the factors investigated, do not correlate with tumour motion within DIBH. The diaphragm is not stable within BH. Applying soft tissue moves is safe to surrounding OARs once due clinical attention is paid to close critical structures.
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The need for quality assurance of the image guidance process in radiotherapy M. Frank 1 , M. Kamphuis 1 , R. De Jong 1 , A. Bel 1 , M. Hulshof 1 , N. Van Wieringen 1 1 Academic Medical Center (AMC)/ University of Amsterdam, Radiotherapie, Amsterdam, The Netherlands Purpose/Objective: A higher awareness of changing anatomy has resulted in an increased complexity and a continuous change of the image guided radiotherapy (IGRT) process. To guarantee the quality of this process we developed a quality assurance (QA) program which involves 1) Inspection of the clinical IGRT process; 2)A check to assess if certain structural abnormalities occur in specific patient groups. This study describes the methodology of our QA program and the results after the first 8 months. Materials and Methods: Each member of the IGRT group performed QA tasks once a week for 4 hours. A checklist was used to assess whether the IGRT process was performed according to protocol and to verify whether there were other abnormalities present. This checklist was developed within an interdisciplinary group discussion. Results of the QA program were documented in an in-house developed computer program. The following items were monitored:1)The number of errors in the IGRT preparation and execution process. 2)Anatomical and other potential dose altering changes that occurred during treatment. Monthly, results were discussed with the members of the IGRT group and, if necessary, feedback is given to the department. After the first 8 months, all QA findings were presented on a departmental level. Results: In an 8 month period 5 dedicated RTTs, all IGRT working group members, reviewed 154 patients with a total of 609 CBCTs, including breast, lung, rectum, oesophagus, gynaecological, bladder and central nervous system patients.
•In 12% of the patients (n=43) anatomical changes were found, mainly in patients treated for lung or oesophagus cancer. 3% of the whole reviewed population needed replanning during treatment.
•7.2 % of the patients showed a change in body contour larger than 1 cm because of weight difference or seroma change.
•17% of the patients showed irregularities in the IGRT preparation process. E.g. registration areas, defining the correct clipbox, correction reference point or match algorithm, were not defined according to protocol. These figures gave us a better insight regarding the IGRT process.
•In 3% of all the CBCTs rotation values were more than 4 degrees (the upper limit for acceptable rotations) the majority (77%) around the left-right axis.
•In 1.6% of the CBCTs a part of the CTV was outside the PTV as a result of tumor progression, tumor shift, or changes in seroma.
•5 patients showed undetected lesions in the lung. In 2 patients after further examination these proved to be malignant.
Conclusions:
The results of the QA program indicates that a substantial part of the treated population show changes which potentially alter dose delivery. In 3% of the investigated population rescanning and replanning was considered necessary. 3rd ESTRO Forum 2015 S909 Furthermore the results of the QA program did give us insight in the IGRT protocol. Based on the data, we have decided to create and perform a training program for all RTTs working on the linear accelerators.
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